Another thing, Mr. Chairman, that I was curious about was Mr. Sapers's comment that elements of a coherent and comprehensive anti-drug strategy should have performance indicators. He suggested a number of them. We spend $120 million to attack this problem.
Could you comment briefly on what kind of indicators are there now and whether they are annual metrics?